Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial

BMJ. 2006 Mar 18;332(7542):632-6. doi: 10.1136/bmj.38737.600880.AE. Epub 2006 Feb 8.


Objective: To determine whether oral protein energy supplements, used long term in children with cystic fibrosis who are moderately malnourished, improve nutritional and other outcomes.

Design: Multicentre randomised controlled trial.

Setting: Seven specialist paediatric cystic fibrosis centres and their associated shared care clinics and seven smaller paediatric cystic fibrosis clinics.

Participants: 102 children with cystic fibrosis, aged between 2 and 15 years, who were moderately malnourished.

Interventions: Oral protein energy supplements in addition to usual dietary advice compared with dietary advice alone, for 12 months.

Main outcome measure: Change in body mass index centile over one year.

Results: Use of supplements was not associated with a change in body mass index centile (mean difference 2.99 centile points, 95% confidence interval -2.70 to 8.68) or other nutritional and spirometric outcomes in this group of children.

Conclusions: Long term use of oral protein energy supplements did not result in an improvement in nutritional status or other clinical outcomes in children with cystic fibrosis who were moderately malnourished. Oral protein energy supplements should not be regarded as an essential part of the management of this group of children.

Trial registration: ISRCTN: 95744468.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adolescent
  • Body Mass Index
  • Child
  • Child, Preschool
  • Cystic Fibrosis / diet therapy*
  • Dietary Proteins / administration & dosage*
  • Dietary Supplements*
  • Energy Intake
  • Humans
  • Protein-Energy Malnutrition / diet therapy


  • Dietary Proteins

Associated data

  • ISRCTN/ISRCTN95744468